Showing 1 - 6 results of 6 for search 'Cesar A. Santa-Maria', query time: 0.03s Refine Results
  1. 1
    Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer

    Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer by Hanwen Wang, Chen Zhao, Cesar A. Santa-Maria, Leisha A. Emens, Aleksander S. Popel

    Published 2022-08-01
    Get full text
    Article
  2. 2
    Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy

    Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy by Sarah Talamantes, Eric Xie, Ricardo L. B. Costa, Melissa Chen, Alfred Rademaker, Cesar A. Santa‐Maria

    Published 2020-10-01
    Get full text
    Article
  3. 3
    In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model

    In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model by Hanwen Wang, Oleg Milberg, Imke H. Bartelink, Paolo Vicini, Bing Wang, Rajesh Narwal, Lorin Roskos, Cesar A. Santa-Maria, Aleksander S. Popel

    Published 2019-05-01
    Get full text
    Article
  4. 4
    Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer

    Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer by Mai F. Tolba, Mai F. Tolba, Cesar A. Santa-Maria, Adriana Albini, Emile R. Chimusa, Basel K. Al-Ramadi, Basel K. Al-Ramadi, Sara M. Tolaney, Sara M. Tolaney

    Published 2021-11-01
    Get full text
    Article
  5. 5
    Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers

    Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers by Nickolas Papadopoulos, Chen Hu, Julie R Brahmer, Patrick M Forde, Evan J Lipson, Jarushka Naidoo, Wei Fu, Joanne Riemer, Chetan Bettegowda, Cesar A Santa-Maria, Matthias Holdhoff, Amanda Barnes, Nafi Aygun, Lawrence Kleinberg, Christopher Douville, Arun Venkatesan, Karisa C Schreck, Alexander Carvajal-Gonzalez, Roisin M Connolly, Kristin J Redmond, Brandi Page, Kenneth W Kinzler, Stuart A Grossman

    Published 2021-08-01
    Get full text
    Article
  6. 6
    A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013

    A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013 by Foluso O. Ademuyiwa, Feng Gao, Cherease R. Street, Ina Chen, Donald W. Northfelt, Robert Wesolowski, Mili Arora, Adam Brufsky, E. Claire Dees, Cesar A. Santa-Maria, Roisin M. Connolly, Jeremy Force, Alvaro Moreno-Aspitia, John M. Herndon, Madelyn Carmody, Sherri R. Davies, Sarah Larson, Kathleen L. Pfaff, Stephanie M. Jones, Jason L. Weirather, Anita Giobbie-Hurder, Scott J. Rodig, Zheng Liu, Ian S. Hagemann, Elad Sharon, William E. Gillanders

    Published 2022-12-01
    Get full text
    Article

Search Tools: